The New Yorker Says It's "Remarkable"

For your weekly reading, we bring you the week's most popular stories from Energy and Capital and our sister site, Wealth Daily. For your weekly reading, we bring you the week's most popular stories from Energy and Capital and our sister site, Wealth Daily. [Energy and Capital logo] The New Yorker Says It's "Remarkable" [Keith Kohl Photo] By [Keith Kohl]( Written Mar 02, 2022 For your weekly reading, we bring you the week's most popular stories from [Energy and Capital]( and our sister site, [Wealth Daily](… [Vlad vs. the World](Putin is shooting himself and his entire country in the foot — and, in the process, losing what little international support he might have had left. [So Much for Those Sanctions](Global markets rallied on word of sanctions against Russia — even Russian markets, because the sanctions aren't really that bad. But how long will it last? [Is Amazon Obligated to Pay You?](After nearly 30 years of exponential growth, Amazon has been quietly slapped with a kind of "fee" to keep running its monopolistic business. And every four months, this “fee” gets distributed to in-the-know investors. Now, you can claim your slice of this jackpot and collect your share of the payout over the next year. All you'll need to do is follow the steps in this presentation. [Wall Street Icon Picks His Top 3 Metaverse Stocks](A massive and revolutionary new upgrade to our technological landscape could drastically increase the wealth of well-positioned investors. Discover our top three plays. [Elon Musk Has Done More for Humanity Than Any of These Fake Social Justice Warriors](Elon Musk donated nearly $6 billion to charity, and the focus is not on the good that will come from that donation but rather the tax benefits that accompany it. [A Brief History of a Plague](After 25 years of intense research, mRNA vaccines have finally been released to the public. Moderna just started clinical trials for its mRNA HIV vaccine. [Billionaires Launch New $1 Trillion Industry]( The birth of a $1 trillion industry is taking place right now, and it will rewrite every aspect of the global economy. If you know how to play this huge change, you could set yourself up for four-digit gains. Because at the heart of it all is a little-known startup making it all possible. [How to Make a Fortune From Olive Presses](The Father of Science could also be considered the Father of Options Trading. Thales of Miletus bet against dominant thinking, and it paid very handsomely... [Something's Happening Here](There's a lot going on in the world today. Jason Williams is here to talk about it and help you protect your portfolio while pocketing profits too. [Future of the Battery Industry](The New Yorker says this “may be the most remarkable substance ever discovered.” In fact, it stands to radically transform a combined $4.59 trillion market seemingly overnight. Investors who understand what this is about could grow their wealth many times over in the months to come… Until next time, [Keith Kohl Signature] Keith Kohl [[follow basic]@KeithKohl1 on Twitter]( A true insider in the technology and energy markets, Keith’s research has helped everyday investors capitalize from the rapid adoption of new technology trends and energy transitions. Keith connects with hundreds of thousands of readers as the Managing Editor of [Energy & Capital](, as well as the investment director of Angel Publishing's [Energy Investor]( and [Technology and Opportunity](. For nearly two decades, Keith has been providing in-depth coverage of the hottest investment trends before they go mainstream — from the shale oil and gas boom in the United States to the red-hot EV revolution currently underway. Keith and his readers have banked hundreds of winning trades on the 5G rollout and on key advancements in robotics and AI technology. Keith’s keen trading acumen and investment research also extend all the way into the complex biotech sector, where he and his readers take advantage of the newest and most groundbreaking medical therapies being developed by nearly 1,000 biotech companies. His network includes hundreds of experts, from M.D.s and Ph.D.s to lab scientists grinding out the latest medical technology and treatments. You can join his vast investment community and target the most profitable biotech stocks in Keith’s [Topline Trader]( advisory newsletter. Browse Our Archives [How to Make a Fortune From Olive Presses]( [Vlad vs. the World]( [Putin Chooses War, and the Extreme Energy Crisis That Comes With It]( [Elon Musk Has Done More for Humanity Than Any of These Fake Social Justice Warriors]( [Pentagon Just Named This Chipmaker Its New "Trusted Supplier"]( --------------------------------------------------------------- This email was sent to {EMAIL}. It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, you may [unsubscribe here]( and view our privacy policy and information on how to manage your subscription. To ensure that you receive future issues of Energy and Capital, please add newsletter@energyandcapital.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance. Energy and Capital, Copyright © 2022, Angel Publishing LLC. All rights reserved. 3 E Read Street, Baltimore, MD 21202. Your privacy is important to us – we will never rent or sell your e-mail or personal information. Please read our [Privacy Policy](. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment advice. Read our [Details and Disclosures.]( ---------------------------------------------------------------